BiotechTube
Pacific Immunology

Pacific Immunology

San Diego, United States· Est.
pacificimmunology.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pacific Immunology is a long-established, private contract research organization (CRO) focused exclusively on custom polyclonal antibody production. It leverages decades of experience, proprietary adjuvants (AdjuLite™), and antigen prediction algorithms to deliver high-titer antibodies against peptide and protein antigens. The company operates a significant 10-acre facility with the capacity for 10,000 projects, serving a global clientele of researchers who require antibodies for basic research, publications, and diagnostic development. Its business model is purely service-based, generating revenue from project fees rather than developing its own therapeutic or diagnostic products.

Antibodies

Technology Platform

Proprietary polyclonal antibody production platform featuring antigen prediction algorithms, AdjuLite™ adjuvants, and guaranteed titer protocols for peptide and protein immunogens.

Opportunities

Growth is driven by sustained demand for research antibodies and the trend toward outsourcing.
The collaboration with Protein Biotechnologies provides a unique offering for diagnostic developers requiring tissue lysate screening, potentially opening a higher-value market segment.
The company's US-based, fully compliant facility is a key asset for clients with specific funding or regulatory requirements.

Risk Factors

Key risks include technological disruption from recombinant antibody methods, increasing regulatory and ethical scrutiny of animal use, and intense competition in the custom services market.
The business is also exposed to cyclical fluctuations in global research and development funding.

Competitive Landscape

Pacific Immunology competes in the custom antibody services market against a range of players, including large reagent suppliers (e.g., GenScript, Thermo Fisher), specialized CROs, and academic core facilities. Its differentiation is based on decades of experience, proprietary adjuvants, strong titer guarantees, and a large-scale, US-based operational facility. Competition is primarily on reliability, quality, cost, and speed of service.

More companies in Biologics / Biosimilars →More companies in United States →